logo

MRM

MEDIROM Healthcare·NASDAQ
--
--(--)
--
--(--)
9.54 / 10
Outperform

Comprehensive review: 9.5/10 score signifies strong fundamentals. Optimistic factors: Interest coverage ratio (EBIT / Interest expense) (%), with caution warranted for Total profit (YoY growth rate %) and Net cash flow from operating activities (YoY growth rate %). Resulting view: outstanding.

Fundamental(9.54)SentimentTechnical

Analysis Checks(1/6)

Basic earnings per share (YoY growth rate %)
Value26.30
Score1/3
Weight-11.00%
1M Return-0.24%
Total profit (YoY growth rate %)
Value-18.14
Score1/3
Weight26.61%
1M Return0.55%
Net cash flow from operating activities (YoY growth rate %)
Value55.21
Score0/3
Weight-53.28%
1M Return-1.27%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score3/3
Weight167.32%
1M Return3.05%
Diluted earnings per share (YoY growth rate %)
Value26.30
Score1/3
Weight2.66%
1M Return0.06%
Net profit attributable to parent company shareholders (YoY growth rate %)
Value-18.60
Score0/3
Weight-32.31%
1M Return-0.71%
Is MRM undervalued or overvalued?
  • MRM scores 9.54/10 on fundamentals and holds a Discounted valuation at present. Backed by its -81.90% ROE, -0.48% net margin, -47.20 P/E ratio, 3.08 P/B ratio, and 579.93% earnings growth, these metrics solidify its Outperform investment rating.